GlassScriptPhysician profile
Dennis Harris
NPI 1477590404
$1,802.37
in general payments reported to CMS, 2019-2025
23 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $242 · 2021: $450 · 2022: $270 · 2023: $196 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $317.94 | 2019-2023 | Belbuca, Xtampza |
| Bioness INC | $277.57 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $210.73 | 2019-2025 | Ztlido |
| Medtronic USA, INC. | $168.52 | 2019-2020 | |
| Medtronic, INC. | $129.41 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Tersera Therapeutics LLC | $95.38 | 2019-2022 | |
| Abbott Laboratories | $68.52 | 2020-2022 | |
| Nevro Corp. | $65.87 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.76 | 2019 | |
| Spr Therapeutics, INC | $57.12 | 2025 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $50.54 | 2019-2021 | |
| Abbvie INC. | $43.90 | 2021 | |
| Nalu Medical, INC. | $42.97 | 2022-2023 | Nalu Neurostimulation System |
| Daiichi Sankyo INC. | $35.93 | 2019 | |
| Pfizer INC. | $27.84 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.63 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $20.51 | 2023 | Horizant |
| Redhill Biopharma INC. | $19.50 | 2021 | |
| Amneal Pharmaceuticals LLC | $19.16 | 2023 | Lioresal (Baclofen) |
| Stimwave Technologies Incorporated | $17.27 | 2019 | |
| Si-Bone, INC. | $16.17 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.67 | 2025 | |
| Grt US Holding, INC. | $14.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.